Proposed Data Collection Submitted for Public Comment and Recommendations, 60608-60609 [2017-27482]
Download as PDF
60608
Federal Register / Vol. 82, No. 244 / Thursday, December 21, 2017 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–0978; Docket No. CDC–2017–
0116]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Emerging Infections Program, a
population-based surveillance via
active, laboratory case finding that is
used for detecting, identifying, and
monitoring emerging pathogens.
DATES: CDC must receive written
comments on or before February 20,
2018.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2017–
0116 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all Federal
comments through the Federal
eRulemaking portal (regulations.gov) or
by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
daltland on DSKBBV9HB2PROD with NOTICES
ADDRESSES:
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Emerging Infections Program (OMB
Control Number 0920–0978, Expiration
Date 2/28/2019)—Revision—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Emerging Infections Programs
(EIPs) are population-based centers of
excellence established through a
network of state health departments
collaborating with academic
institutions; local health departments;
public health and clinical laboratories;
infection control professionals; and
healthcare providers. EIPs assist in
local, state, and national efforts to
prevent, control, and monitor the public
health impact of infectious diseases.
Activities of the EIPs fall into the
following general categories: (1) Active
surveillance; (2) applied public health
epidemiologic and laboratory activities;
(3) implementation and evaluation of
pilot prevention/intervention projects;
and (4) flexible response to public
health emergencies. Activities of the
EIPs are designed to: (1) Address issues
that the EIP network is particularly
suited to investigate; (2) maintain
sufficient flexibility for emergency
response and new problems as they
arise; (3) develop and evaluate public
health interventions to inform public
health policy and treatment guidelines;
(4) incorporate training as a key
function; and (5) prioritize projects that
lead directly to the prevention of
disease.
A revision is being submitted to make
existing forms clearer and to add several
new forms: ABCs Severe GAS Infection
Supplemental Form, HAIC Multi-site
Gram-Negative Bacilli Case Report Form
for Carbapenem-resistant Pseudomonas
aeruginosa (CR–PA), HAIC Multi-site
Gram-Negative Surveillance Initiative—
Extended-Spectrum Beta-LactamaseProducing Enterobacteriaceae (MuGSI–
ESBL), HAIC Invasive Methicillinsensitive Staphylococcus aureus
(MSSA), and HAIC Candidemia Case
Report Form. These forms will allow the
EIP to better detect, identify, and
monitor emerging pathogens. The
estimates of the infection incidence
generated by this collection provide the
foundation for a variety of
epidemiologic studies to explore risk
factors, spectrum of disease, and
prevention strategies.
The total estimated burden is 40,347
hours. There is no cost to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State Health Department ...............
ABCs Case Report Form ......................................................................
VerDate Sep<11>2014
20:57 Dec 20, 2017
Jkt 244001
PO 00000
Frm 00031
Fmt 4703
Number of
responses
per
respondent
Number of
respondents
Type of respondents
Sfmt 4703
10
E:\FR\FM\21DEN1.SGM
21DEN1
809
Average
burden per
response
(in hours)
20/60
Total
burden
(in hours)
2,697
60609
Federal Register / Vol. 82, No. 244 / Thursday, December 21, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
ABCs Invasive Pneumococcal Disease in Children Case Report
Form.
ABCs Surveillance for Non-Invasive Pneumococcal Pneumonia
(SNiPP) Case Report Form.
ABCs H.influenzae Neonatal Sepsis Expanded Surveillance Form ....
ABCs Severe GAS Infection Supplemental Form—NEW FORM ........
ABCs Neonatal Infection Expanded Tracking Form .............................
FoodNet Campylobacter .......................................................................
FoodNet Cryptosporidium .....................................................................
FoodNet Cyclospora .............................................................................
FoodNet Listeria monocytogenes .........................................................
FoodNet Salmonella .............................................................................
FoodNet Shiga toxin producing E. coli .................................................
FoodNet Shigella ..................................................................................
FoodNet Vibrio ......................................................................................
FoodNet Yersinia ..................................................................................
FoodNet Hemolytic Uremic Syndrome .................................................
Influenza Hospitalization Surveillance Network Case Report Form .....
Influenza Hospitalization Surveillance Project Vaccination Phone
Script Consent Form (English).
Influenza Hospitalization Surveillance Project Vaccination Phone
Script Consent Form (Spanish).
Influenza Hospitalization Surveillance Project Provider Vaccination
History Fax Form (Children/Adults).
HAIC CDI Case Report Form ...............................................................
HAIC Multi-site Gram-Negative Bacilli Case Report Form (MuGSI–
CRE/CRAB).
HAIC Multi-site Gram-Negative Bacilli Case Report Form for
Carbapenem-resistant Pseudomonas aeruginosa(CR–PA)—NEW
FORM.
HAIC Multi-site Gram-Negative Surveillance Initiative—ExtendedSpectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI–
ESBL)—NEW FORM.
HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA) ...
HAIC Invasive Methicillin-sensitive Staphylococcus aureus (MSSA)—
NEW FORM.
HAIC Candidemia Case Report Form—NEW FORM ..........................
Total ........................................
...............................................................................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–27482 Filed 12–20–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–18EV; Docket No. CDC–2017–
0105]
daltland on DSKBBV9HB2PROD with NOTICES
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
SUMMARY:
VerDate Sep<11>2014
20:57 Dec 20, 2017
Jkt 244001
Frm 00032
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Total
burden
(in hours)
10
22
10/60
37
10
125
10/60
208
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
6
136
37
850
130
3
13
827
190
290
25
30
10
1,000
333
10/60
20/60
20/60
21/60
10/60
10/60
20/60
21/60
20/60
10/60
10/60
10/60
1
25/60
5/60
10
453
123
2,975
217
5
43
2,895
633
483
42
50
100
4,167
278
10
333
5/60
278
10
333
5/60
278
10
10
1,650
500
30/60
20/60
8,250
1,667
10
344
45/60
2,580
10
1,200
20/60
4,000
10
10
609
1,035
20/60
20/60
2,030
3,450
9
800
20/60
2,400
....................
....................
....................
40,347
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Enhanced Surveillance for
Histoplasmosis. CDC will collect state
health department and patient furnished
histoplasmosis case data.
DATES: CDC must receive written
comments on or before February 20,
2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0105 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
PO 00000
Number of
responses
per
respondent
Number of
respondents
Form name
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all Federal
comments through the Federal
eRulemaking portal (regulations.gov) or
by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
E:\FR\FM\21DEN1.SGM
21DEN1
Agencies
[Federal Register Volume 82, Number 244 (Thursday, December 21, 2017)]
[Notices]
[Pages 60608-60609]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27482]
[[Page 60608]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-0978; Docket No. CDC-2017-0116]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Emerging Infections Program, a
population-based surveillance via active, laboratory case finding that
is used for detecting, identifying, and monitoring emerging pathogens.
DATES: CDC must receive written comments on or before February 20,
2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0116 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all Federal comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Emerging Infections Program (OMB Control Number 0920-0978,
Expiration Date 2/28/2019)--Revision--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases.
Activities of the EIPs fall into the following general categories:
(1) Active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies. Activities of the EIPs are designed to: (1) Address
issues that the EIP network is particularly suited to investigate; (2)
maintain sufficient flexibility for emergency response and new problems
as they arise; (3) develop and evaluate public health interventions to
inform public health policy and treatment guidelines; (4) incorporate
training as a key function; and (5) prioritize projects that lead
directly to the prevention of disease.
A revision is being submitted to make existing forms clearer and to
add several new forms: ABCs Severe GAS Infection Supplemental Form,
HAIC Multi-site Gram-Negative Bacilli Case Report Form for Carbapenem-
resistant Pseudomonas aeruginosa (CR-PA), HAIC Multi-site Gram-Negative
Surveillance Initiative--Extended-Spectrum Beta-Lactamase-Producing
Enterobacteriaceae (MuGSI-ESBL), HAIC Invasive Methicillin-sensitive
Staphylococcus aureus (MSSA), and HAIC Candidemia Case Report Form.
These forms will allow the EIP to better detect, identify, and monitor
emerging pathogens. The estimates of the infection incidence generated
by this collection provide the foundation for a variety of
epidemiologic studies to explore risk factors, spectrum of disease, and
prevention strategies.
The total estimated burden is 40,347 hours. There is no cost to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average
Number of responses burden per Total
Type of respondents Form name respondents per response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
State Health Department............. ABCs Case Report Form. 10 809 20/60 2,697
[[Page 60609]]
ABCs Invasive 10 22 10/60 37
Pneumococcal Disease
in Children Case
Report Form.
ABCs Surveillance for 10 125 10/60 208
Non-Invasive
Pneumococcal
Pneumonia (SNiPP)
Case Report Form.
ABCs H.influenzae 10 6 10/60 10
Neonatal Sepsis
Expanded Surveillance
Form.
ABCs Severe GAS 10 136 20/60 453
Infection
Supplemental Form--
NEW FORM.
ABCs Neonatal 10 37 20/60 123
Infection Expanded
Tracking Form.
FoodNet Campylobacter. 10 850 21/60 2,975
FoodNet 10 130 10/60 217
Cryptosporidium.
FoodNet Cyclospora.... 10 3 10/60 5
FoodNet Listeria 10 13 20/60 43
monocytogenes.
FoodNet Salmonella.... 10 827 21/60 2,895
FoodNet Shiga toxin 10 190 20/60 633
producing E. coli.
FoodNet Shigella...... 10 290 10/60 483
FoodNet Vibrio........ 10 25 10/60 42
FoodNet Yersinia...... 10 30 10/60 50
FoodNet Hemolytic 10 10 1 100
Uremic Syndrome.
Influenza 10 1,000 25/60 4,167
Hospitalization
Surveillance Network
Case Report Form.
Influenza 10 333 5/60 278
Hospitalization
Surveillance Project
Vaccination Phone
Script Consent Form
(English).
Influenza 10 333 5/60 278
Hospitalization
Surveillance Project
Vaccination Phone
Script Consent Form
(Spanish).
Influenza 10 333 5/60 278
Hospitalization
Surveillance Project
Provider Vaccination
History Fax Form
(Children/Adults).
HAIC CDI Case Report 10 1,650 30/60 8,250
Form.
HAIC Multi-site Gram- 10 500 20/60 1,667
Negative Bacilli Case
Report Form (MuGSI-
CRE/CRAB).
HAIC Multi-site Gram- 10 344 45/60 2,580
Negative Bacilli Case
Report Form for
Carbapenem-resistant
Pseudomonas
aeruginosa(CR-PA)--NE
W FORM.
HAIC Multi-site Gram- 10 1,200 20/60 4,000
Negative Surveillance
Initiative--Extended-
Spectrum Beta-
Lactamase-Producing
Enterobacteriaceae
(MuGSI-ESBL)--NEW
FORM.
HAIC Invasive 10 609 20/60 2,030
Methicillin-resistant
Staphylococcus aureus
(MRSA).
HAIC Invasive 10 1,035 20/60 3,450
Methicillin-sensitive
Staphylococcus aureus
(MSSA)--NEW FORM.
HAIC Candidemia Case 9 800 20/60 2,400
Report Form--NEW FORM.
---------------------------------------------------
Total........................... ...................... ........... ........... ........... 40,347
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-27482 Filed 12-20-17; 8:45 am]
BILLING CODE 4163-18-P